The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments

HJ Kim, SJ Kang, C Kim, GH Kim, S Jeon, JM Lee… - Neurobiology of …, 2013 - Elsevier
Neuropsychiatric symptoms (NPS) affect the quality of life of patients with dementia and
increase the burden on caregivers. We aimed to evaluate how small vessel disease (SVD) …

Neuropsychiatric correlates of small vessel disease progression in incident cognitive decline: independent and interactive effects

CN Kan, B Gyanwali, S Hilal, KP Ng… - Journal of …, 2020 - content.iospress.com
Background: Cerebral small vessel disease (SVD) and neuropsychiatric symptoms (NPS)
independently increase the risk of cognitive decline. While their co-existence has been …

[HTML][HTML] Association between behavioral and psychological symptoms and cerebral small vessel disease MRI findings in memory clinic patients

M Shinohara, K Matsuda, Y Ii, K Tabei… - Frontiers in aging …, 2023 - frontiersin.org
Objectives: Cerebral small vessel disease (SVD) is commonly observed among elderly
individuals with cognitive impairment and has been recognized as a vascular contributor to …

Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment

JH Park, SW Seo, C Kim, SH Kim, GH Kim, ST Kim… - Neurobiology of …, 2014 - Elsevier
Cerebrovascular disease (CVD) and amyloid burden are the most frequent pathologies in
subjects with cognitive impairment. However, the relationship between CVD, amyloid …

Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment

MJ Lee, SW Seo, DL Na, C Kim, JH Park… - JAMA …, 2014 - jamanetwork.com
Importance Cerebrovascular disease (CVD) and Alzheimer disease are significant causes of
cognitive impairment in the elderly. However, few studies have evaluated the relationship …

Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia

BS Ye, SW Seo, JH Kim, GH Kim, H Cho, Y Noh… - Neurology, 2015 - AAN Enterprises
Objective: To determine the independent and synergistic effects of amyloid and small vessel
disease (SVD) burden on longitudinal cognitive decline in patients with subcortical vascular …

Neuropsychiatric symptoms in Alzheimer disease, vascular dementia, and mixed dementia

CJ Anor, S O'Connor, A Saund, DF Tang-Wai… - Neurodegenerative …, 2017 - karger.com
Abstract Background/Aims: Neuropsychiatric symptoms (NPS) are common in Alzheimer
disease (AD) and vascular dementia (VaD), and are distressful to patients and caregivers …

The longitudinal assessment of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease and their association with white matter …

CJ Anor, M Dadar, DL Collins, MC Tartaglia - … : Cognitive Neuroscience and …, 2021 - Elsevier
Abstract Background Neuropsychiatric symptoms (NPSs) are common in Alzheimer's
disease (AD). NPSs contribute to patients' distress, caregiver burden, and …

In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease

A Low, E Mak, M Malpetti, L Passamonti… - Journal of Neurology …, 2021 - jnnp.bmj.com
Introduction Associations between cerebral small vessel disease (SVD) and inflammation
have been largely examined using peripheral blood markers of inflammation, with few …

CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study

A Low, MA Prats-Sedano, JD Stefaniak… - Journal of Neurology …, 2022 - jnnp.bmj.com
Background Markers of cerebrovascular disease are common in dementia, and may be
present before dementia onset. However, their clinical relevance in midlife adults at risk of …